Clinical trial
Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and…
NCT00333918 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00333918 |
|---|---|
| Title | Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery |
| Official title | Efficacy and Safety Study of Topical Bromfenac Ophthalmic Solution vs. Placebo for Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain, Inflammation |
| Intervention type | Drug |
| Interventions | bromfenac ophthalmic solution, placebo comparator |
| Enrollment | 522 |
| Start date | Jun 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Jun 6, 2006 |
| Last update posted | Feb 15, 2013 |
| Countries | United States |
At a glance
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: